Skip to main content
COFCO BIOTECHNOLOGY CO., LTD. logo

COFCO BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 000930 ISIN · CNE000000ZR7 LEI · 300300CSR7RNP1P1CP32 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2018-06-15 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000930

About COFCO BIOTECHNOLOGY CO., LTD.

https://www.cofcotech.com

COFCO Biotechnology Co., Ltd. specializes in the deep processing of agricultural products, primarily corn, cassava, and other grains. The company operates as a major producer of fuel ethanol, edible alcohol, and starch-based products. Its portfolio includes a wide range of sweeteners such as fructose and glucose, as well as organic acids like citric acid and lactic acid. Additionally, the firm develops bio-based materials and biochemical products including amino acids and feed additives. Serving diverse sectors such as food and beverage, pharmaceuticals, and renewable energy, the company focuses on technological innovation in biotechnology to enhance resource efficiency and promote sustainable industrial applications. It maintains a significant presence in the global supply chain for bio-based chemicals and ingredients.

Recent filings

Filing Released Lang Actions
COFCO Biochemical Holdings Limited审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an "审计报告" which translates to "Audit Report". It contains detailed auditor opinions, audit basis, responsibilities of management and auditors, and extensive financial statements including balance sheets, profit and loss statements, and cash flow statements for the years 2016 and 2017. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a standalone audit report rather than a full annual report or other filing types. There is no indication that this is a certification letter or a report publication announcement. Therefore, the document fits the definition of an Audit Report / Information (AR). FY 2017
2018-06-15 Chinese
中国国际金融股份有限公司关于公司本次交易产业政策和交易类型之专项财务顾问核查意见
M&A Activity Classification · 95% confidence The document is a specialized financial advisor's verification opinion regarding a major asset restructuring transaction involving COFCO Biochemical (Anhui) Co., Ltd. It references regulatory bodies such as the China Securities Regulatory Commission and Shenzhen Stock Exchange, and discusses compliance with merger and acquisition regulations, industry classifications, transaction types, and control changes. The document is a formal independent financial advisor's report on the transaction's nature, industry classification, issuance of shares, and control implications. It is not a full annual or interim financial report, nor is it a brief announcement or a certification letter. The content aligns with a detailed advisory opinion related to a merger or acquisition transaction rather than a general regulatory filing or announcement. Therefore, the document best fits the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids. The document length (3061 characters) and detailed content support this classification with high confidence.
2018-06-15 Chinese
独立董事关于发行股份购买资产暨关联交易的事前认可意见
Capital/Financing Update Classification · 95% confidence The document is titled as an independent directors' prior approval opinion regarding the issuance of shares to purchase assets and related party transactions. It discusses the fairness, legality, and compliance of the transaction, including pricing, asset valuation, and procedural adherence. The document is a formal opinion from independent directors on a specific transaction rather than a full financial report or announcement of voting results. It does not contain financial statements or earnings data, nor is it a regulatory announcement or a proxy solicitation. The content aligns with a Capital/Financing Update as it relates to issuance of shares and asset purchase transactions. The document length is short (1854 characters), but it is not merely an announcement of a report publication, rather it is a formal opinion on a financing transaction. Therefore, the best fitting category is Capital/Financing Update (CAP).
2018-06-15 Chinese
七届九次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the seventh session of the ninth board meeting of COFCO Biochemical (Anhui) Co., Ltd. It includes voting results on various proposals related to a major asset acquisition by issuing shares, including approval of the asset purchase plan, pricing, payment method, issuance details, lock-up periods, and related audit and evaluation reports. The document is a formal board meeting resolution announcement, focusing on management decisions and approvals rather than the full audit report or financial statements themselves. It does not contain comprehensive financial data or the full audit report text but references these reports as part of the agenda. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management, including approvals of major transactions and related corporate governance matters.
2018-06-15 Chinese
中国国际金融股份有限公司关于本次重组前12个月内上市公司购买、出售资产的核查意见
Regulatory Filings Classification · 95% confidence The document is a short statement from an independent financial advisor regarding the review of asset purchases and sales by a listed company in the 12 months prior to a proposed restructuring involving share issuance. It explicitly states an opinion on the absence of significant asset transactions related to the restructuring. The document is very brief (496 characters) and serves as a verification or certification related to the restructuring process, not a full financial report or detailed announcement. It does not contain financial statements or detailed analysis, nor is it a general regulatory announcement or a voting result. Given its nature as an independent advisor's opinion on asset transactions in the context of a restructuring, it fits best under Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories and includes certifications and opinions related to corporate actions.
2018-06-15 Chinese
中国国际金融股份有限公司关于公司发行股份购买资产暨关联交易之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" related to a transaction involving issuance of shares to purchase assets and related party transactions. It includes detailed sections on transaction overview, company background, asset evaluation, financial impact, and legal and regulatory compliance. The content is comprehensive and focused on a major asset restructuring and related financial advisory opinions. This type of document is typical of a standalone audit or advisory report related to a significant corporate transaction, not a full annual or quarterly report, nor a simple announcement. It is not a proxy, voting result, or earnings release. The presence of detailed asset evaluation, transaction terms, and independent advisor opinions aligns with the category of Audit Report / Information (AR). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is AR with high confidence. FY 2018
2018-06-15 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.